These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


285 related items for PubMed ID: 9641324

  • 21. The alpha-adrenoceptor antagonist, zolertine, inhibits alpha1D- and alpha1A-adrenoceptor-mediated vasoconstriction in vitro.
    Ibarra M, Hong E, Villalobos-Molina R.
    J Auton Pharmacol; 2000 Jun; 20(3):139-45. PubMed ID: 11193002
    [Abstract] [Full Text] [Related]

  • 22. Alpha1-adrenoceptor subtypes mediating vasoconstriction in the carotid circulation of anaesthetized pigs: possible avenues for antimigraine drug development.
    Willems EW, Heiligers JP, De Vries P, Kapoor K, Tom B, Villalón CM, Saxena PR.
    Cephalalgia; 2001 Mar; 21(2):110-9. PubMed ID: 11422093
    [Abstract] [Full Text] [Related]

  • 23. The isolated in vitro perfused spiral modiolar artery: pressure dependence of vasoconstriction.
    Wangemann P, Gruber DD.
    Hear Res; 1998 Jan; 115(1-2):113-8. PubMed ID: 9472740
    [Abstract] [Full Text] [Related]

  • 24. Alpha1D-adrenoceptor-induced relaxation on rat carotid artery is impaired during the endothelial dysfunction evoked in the early stages of hyperhomocysteinemia.
    de Andrade CR, Fukada SY, Olivon VC, de Godoy MA, Haddad R, Eberlin MN, Cunha FQ, de Souza HP, Laurindo FR, de Oliveira AM.
    Eur J Pharmacol; 2006 Aug 14; 543(1-3):83-91. PubMed ID: 16828078
    [Abstract] [Full Text] [Related]

  • 25. In vitro alpha1-adrenoceptor pharmacology of Ro 70-0004 and RS-100329, novel alpha1A-adrenoceptor selective antagonists.
    Williams TJ, Blue DR, Daniels DV, Davis B, Elworthy T, Gever JR, Kava MS, Morgans D, Padilla F, Tassa S, Vimont RL, Chapple CR, Chess-Williams R, Eglen RM, Clarke DE, Ford AP.
    Br J Pharmacol; 1999 May 14; 127(1):252-8. PubMed ID: 10369480
    [Abstract] [Full Text] [Related]

  • 26. Evidence for a calcium-sensing receptor in the vascular smooth muscle cells of the spiral modiolar artery.
    Wonneberger K, Scofield MA, Wangemann P.
    J Membr Biol; 2000 Jun 01; 175(3):203-12. PubMed ID: 10833530
    [Abstract] [Full Text] [Related]

  • 27. Evidence of alpha1-adrenoceptor functional changes in omental arteries of patients with end-stage renal disease.
    Cruz-Domínguez MP, Villalobos-Molina R, Miliar-García A, Montes-Cortés DH, Reséndiz-Ramírez AC, Asbun-Bojalil J, Cervantes-Cruz J, Castillo-Hernández MC, Castillo-Henkel C.
    Auton Autacoid Pharmacol; 2008 Jan 01; 28(1):19-27. PubMed ID: 18257748
    [Abstract] [Full Text] [Related]

  • 28. Alpha1A-adrenoceptors predominate in the control of blood pressure in mouse mesenteric vascular bed.
    Martínez-Salas SG, Campos-Peralta JM, Pares-Hipolito J, Gallardo-Ortíz IA, Ibarra M, Villalobos-Molina R.
    Auton Autacoid Pharmacol; 2007 Jul 01; 27(3):137-42. PubMed ID: 17584443
    [Abstract] [Full Text] [Related]

  • 29. The alpha(1A)-adrenoceptor subtype mediates contraction in rat femoral resistance arteries.
    Jarajapu YP, Hillier C, MacDonald A.
    Eur J Pharmacol; 2001 Jun 22; 422(1-3):127-35. PubMed ID: 11430923
    [Abstract] [Full Text] [Related]

  • 30. Noradrenergic vasoconstriction of pig prostatic small arteries.
    Recio P, Orensanz LM, Martínez MP, Navarro-Dorado J, Bustamante S, García-Sacristán A, Prieto D, Hernández M.
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Feb 22; 376(6):397-406. PubMed ID: 18172615
    [Abstract] [Full Text] [Related]

  • 31. Characterization of subtype of alpha1-adrenoceptor mediating vasoconstriction in perfused rat hind limb.
    Zhu W, Zhang Y, Han C.
    Eur J Pharmacol; 1997 Jun 18; 329(1):55-61. PubMed ID: 9218684
    [Abstract] [Full Text] [Related]

  • 32. Differential antagonism by conotoxin rho-TIA of contractions mediated by distinct alpha1-adrenoceptor subtypes in rat vas deferens, spleen and aorta.
    Lima V, Mueller A, Kamikihara SY, Raymundi V, Alewood D, Lewis RJ, Chen Z, Minneman KP, Pupo AS.
    Eur J Pharmacol; 2005 Jan 31; 508(1-3):183-92. PubMed ID: 15680270
    [Abstract] [Full Text] [Related]

  • 33. Neurogenic double-peaked vasoconstriction of human gastroepiploic artery is mediated by both alpha1- and alpha2-adrenoceptors.
    Fukui D, Yang XP, Chiba S.
    Br J Pharmacol; 2005 Mar 31; 144(6):737-42. PubMed ID: 15685216
    [Abstract] [Full Text] [Related]

  • 34. alpha1A-adrenergic receptor mediated pressor response to phenylephrine in anesthetized rat.
    Qi X, Weizhong Z, Zhizhen L, Youyi Z, Qide H.
    Sci China C Life Sci; 2004 Feb 31; 47(1):59-65. PubMed ID: 15382677
    [Abstract] [Full Text] [Related]

  • 35. Effects of a calcium antagonist and of the adrenergic system on spontaneous vasomotion and mean arteriolar diameter in the hamster cheek pouch: influence of buflomedil.
    Bouskela E, Cyrino FZ.
    Int J Microcirc Clin Exp; 1997 Feb 31; 17(4):164-74. PubMed ID: 9378566
    [Abstract] [Full Text] [Related]

  • 36. Functional assessment of alpha 1-adrenoceptor subtypes in porcine coronary artery.
    Yan M, Zhang Y, Du XJ, Han C.
    Clin Exp Pharmacol Physiol; 1998 Sep 31; 25(9):682-5. PubMed ID: 9750956
    [Abstract] [Full Text] [Related]

  • 37. Pharmacological characterization of alpha1-adrenoceptors in mouse isolated femoral small arteries.
    Zacharia J, Hillier C, Macdonald A.
    Eur J Pharmacol; 2004 Oct 25; 503(1-3):155-63. PubMed ID: 15496310
    [Abstract] [Full Text] [Related]

  • 38. The nitric oxide synthase inhibitor L-NMMA potentiates noradrenaline-induced vasoconstriction: effects of the alpha2-receptor antagonist yohimbine.
    Bruck H, Gössl M, Spitthöver R, Schäfers RF, Kohnle M, Philipp T, Wenzel RR.
    J Hypertens; 2001 May 25; 19(5):907-11. PubMed ID: 11393674
    [Abstract] [Full Text] [Related]

  • 39. Functional characterization of alpha(1)-adrenoceptor subtypes in human skeletal muscle resistance arteries.
    Jarajapu YP, Coats P, McGrath JC, Hillier C, MacDonald A.
    Br J Pharmacol; 2001 Jul 25; 133(5):679-86. PubMed ID: 11429392
    [Abstract] [Full Text] [Related]

  • 40. Prazosin has low potency at α1A-adrenoceptors and high potency at α1D -adrenoceptors in rat vas deferens.
    Docherty JR.
    Auton Autacoid Pharmacol; 2013 Oct 25; 33(3-4):49-57. PubMed ID: 24074250
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 15.